Literature DB >> 25301055

New onset of myasthenia gravis 10 years after proton beam therapy for thymoma.

Takahiro Karasaki1, Tomohiro Murakawa2, Kazuhiro Nagayama1, Jun-Ichi Nitadori1, Masaki Anraku1, Yoshinao Kikuchi3, Aya Shinozaki-Ushiku3, Hiroshi Igaki4, Jun Nakajima1.   

Abstract

A 36-year-old woman underwent proton beam therapy for encapsulated type B1 thymoma for curative intent at 66 GyE. Radiographically partial response was achieved. Although the tumor size had been stable since that time, she developed systemic myasthenia gravis 10 years after the proton therapy. Extended thymectomy was performed. There were no adhesions between the tumor and the pericardium, and there were no adhesions also between the tumor and the sternum, probably due to the favor of Bragg peak effect. Extensive hyalinization with small foci of viable tumor cells showing degenerated type A-like morphology was observed in the resected tumor. Whether the viable cells represented recurrence with degenerative changes or de novo tumor formation was unable to be determined, and whether the viable cells were responsible for the onset of myasthenia gravis remained unclear.

Entities:  

Keywords:  Myasthenia gravis; Radiation therapy (proton beam therapy); Thymoma

Mesh:

Year:  2014        PMID: 25301055     DOI: 10.1007/s11748-014-0484-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

1.  Survival after extended thymectomy for thymoma.

Authors:  Miki Sakamoto; Tomohiro Murakawa; Chihiro Konoeda; Yuta Inoue; Kentaro Kitano; Atsushi Sano; Masashi Fukayama; Jun Nakajima
Journal:  Eur J Cardiothorac Surg       Date:  2011-10-18       Impact factor: 4.191

2.  Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Authors:  Joe Y Chang; Xiaodong Zhang; Xiaochun Wang; Yixiu Kang; Beverly Riley; Stephen Bilton; Radhe Mohan; Ritsuko Komaki; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-06       Impact factor: 7.038

Review 3.  The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma.

Authors:  Thomas Björk-Eriksson; Göran Bjelkengren; Bengt Glimelius
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

4.  Is thymectomy necessary in nonmyasthenic patients with early thymoma?

Authors:  Yen-Chiang Tseng; Chih-Cheng Hsieh; Hsin-Yi Huang; Chien-Sheng Huang; Wen-Hu Hsu; Biing-Shiun Huang; Min-Hsiung Huang; Han-Shui Hsu
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

Review 5.  Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.

Authors:  Meinoshin Okumura; Yoshitaka Fujii; Hiroyuki Shiono; Masayoshi Inoue; Masato Minami; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

Review 6.  Therapy for thymic epithelial tumors.

Authors:  Kazuya Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-10

7.  Pathologic radioresponse of preoperatively irradiated invasive thymomas.

Authors:  Takuya Onuki; Shigemi Ishikawa; Tatsuo Yamamoto; Hiromichi Ito; Mitsuaki Sakai; Masataka Onizuka; Yuzuru Sakakibara; Tatsuo Iijima; Masayuki Noguchi; Kiyoshi Ohara
Journal:  J Thorac Oncol       Date:  2008-03       Impact factor: 15.609

8.  Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.

Authors:  Jun Nakajima; Tomohiro Murakawa; Takeshi Fukami; Atsushi Sano; Shinichi Takamoto; Hiroshi Ohtsu
Journal:  Ann Thorac Surg       Date:  2008-09       Impact factor: 4.330

9.  Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma?

Authors:  Kazuo Nakagawa; Hisao Asamura; Hiroyuki Sakurai; Shun-ichi Watanabe; Koji Tsuta
Journal:  J Surg Oncol       Date:  2013-11-19       Impact factor: 3.454

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.